Stock Analysis on Net

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

$24.99

Common-Size Balance Sheet: Assets

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Vertex Pharmaceuticals Inc., common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Inventories
Tax-related prepaid and receivables
Prepaid expenses
Fair value of cash flow hedges
Other
Prepaid expenses and other current assets
Current assets
Property and equipment, net
Goodwill
Other intangible assets, net
Deferred tax assets
Operating lease assets
Long-term marketable securities
Other assets
Non-current assets
Total assets

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The composition of assets has undergone significant shifts between 2021 and 2025. A notable trend is the substantial decrease in the proportion of current assets relative to total assets, while the share of non-current assets has increased correspondingly. This suggests a strategic shift towards longer-term investments and a potential decrease in short-term liquidity focus.

Current Assets
Current assets, representing 71.18% of total assets in 2021, experienced a decline to 43.68% by 2025. This decrease is primarily driven by a significant reduction in cash and cash equivalents, which fell from 50.59% to 19.83% over the same period. Accounts receivable remained relatively stable, fluctuating between 6.88% and 8.46% of total assets. Inventories exhibited a gradual increase, rising from 2.63% to 6.58%, indicating a potential build-up in stock. The proportion of prepaid expenses and other current assets also decreased slightly.
Non-Current Assets
Non-current assets increased from 28.82% of total assets in 2021 to 56.32% in 2025. This growth is largely attributable to increases in deferred tax assets and long-term marketable securities. Deferred tax assets grew substantially, from 6.96% to 11.30%. Long-term marketable securities emerged as a significant component, increasing from a negligible amount in 2021 to 22.28% in 2025. Property and equipment, net, and goodwill experienced moderate declines as percentages of total assets. Other intangible assets decreased significantly from 2023 to 2025.
Cash Position
The company’s cash position, as a percentage of total assets, experienced a dramatic decrease. From a high of 50.59% in 2021, it fell to 19.83% in 2025. This suggests a significant deployment of cash into other assets, particularly long-term marketable securities and deferred tax assets. The decrease in cash is the most prominent change observed in the asset composition.
Asset Mix Shift
The asset mix has shifted considerably from a cash-heavy profile in 2021 to a more diversified structure in 2025, with a greater emphasis on long-term investments and deferred tax assets. The increase in operating lease assets from 2.46% to 6.09% also contributes to this diversification. This shift may indicate a change in the company’s long-term strategy, potentially focusing on growth initiatives and tax optimization.

Overall, the asset composition demonstrates a strategic reallocation of resources over the five-year period. The reduction in liquid assets, coupled with the increase in long-term investments and deferred tax assets, suggests a long-term oriented financial strategy.